KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 5129.86M
Enterprise Value 371.76M
Trailing P/E N/A
Forward P/E 1-4.75
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)25.02
Price/Book (mrq)1.46
Enterprise Value/Revenue 313.83
Enterprise Value/EBITDA 6-2.59

Trading Information

Stock Price History

Beta (3Y Monthly) 4.02
52-Week Change 3-34.73%
S&P500 52-Week Change 37.98%
52 Week High 34.3500
52 Week Low 30.9400
50-Day Moving Average 31.3521
200-Day Moving Average 32.2893

Share Statistics

Avg Vol (3 month) 3489.64k
Avg Vol (10 day) 3517.53k
Shares Outstanding 5113.91M
Float 90.83M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Aug. 30, 2019) 4976.29k
Short Ratio (Aug. 30, 2019) 41.81
Short % of Float (Aug. 30, 2019) 4N/A
Short % of Shares Outstanding (Aug. 30, 2019) 40.86%
Shares Short (prior month Jul. 31, 2019) 41.01M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 28/1
Last Split Date 3May 24, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 31, 2018
Most Recent Quarter (mrq)Jun. 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-543.62%

Management Effectiveness

Return on Assets (ttm)-32.32%
Return on Equity (ttm)-63.28%

Income Statement

Revenue (ttm)5.19M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)297.36k
EBITDA -27.72M
Net Income Avi to Common (ttm)-30.33M
Diluted EPS (ttm)-0.4100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)55.79M
Total Cash Per Share (mrq)0.49
Total Debt (mrq)3.39M
Total Debt/Equity (mrq)3.80
Current Ratio (mrq)7.87
Book Value Per Share (mrq)0.78

Cash Flow Statement

Operating Cash Flow (ttm)-22.3M
Levered Free Cash Flow (ttm)-15.37M